SCHEDULE 13D/AAccepted Oct 8, 6:39 PM ET
ArriVent BioPharma, Inc. SCHEDULE 13D/A
Accepted (ET)
6:39 PM
Oct 8, 2026
Filed
Oct 8, 2026
Documents
2
Size
33.8 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.